# Accele BioPharma, Inc. — Form D

Accele BioPharma, Inc. of OKLAHOMA CITY, OK, a company, filed a Form D exempt-offering notice with the SEC on 2012-09-04. The offering totals $2.6M, of which $2.6M was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2012-09-04
- Form: D
- Accession: 0001556986-12-000001
- Industry: Other Health Care
- Exemptions: 06
- Total offering: $2.6M
- Amount sold: $2.6M
- Investors: 6
- Security types: equity
- Revenue range: Decline to Disclose

## Issuer

- Name: Accele BioPharma, Inc.
- CIK: 0001556986
- Entity type: Corporation
- Jurisdiction: OKLAHOMA
- Incorporated: 2012
- Address: 655 RESEARCH PARKWAY, OKLAHOMA CITY, OK, 74104
- Phone: 919-360-7010

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Clayton Duncan | Director | Oklahoma City, OK |
| CARL EDWARDS | Director | Oklahoma City, OK |
| Stephen Prescott | Director | Oklahoma City, OK |
| Clayton Duncan | Executive Officer | Oklahoma City, OK |

## More

- [CIK 1556986 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1556986&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001556986-12-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.